PCR64 Patient Satisfaction With 6-Monthly Versus 3-Monthly Paliperidone Palmitate Long-Acting Injectable for Schizophrenia Treatment: Results From a Phase-3, Randomised, Noninferiority Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1999
https://www.valueinhealthjournal.com/article/S1098-3015(22)04204-8/fulltext
Title :
PCR64 Patient Satisfaction With 6-Monthly Versus 3-Monthly Paliperidone Palmitate Long-Acting Injectable for Schizophrenia Treatment: Results From a Phase-3, Randomised, Noninferiority Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04204-8&doi=10.1016/j.jval.2022.09.1999
First page :
Section Title :
Open access? :
No
Section Order :
11553